{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. jmllovet@clinic.cat",
    "Liver Cancer Translational Research Group - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Liver Unit-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. jmllovet@clinic.cat",
    "Mount Sinai Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. jmllovet@clinic.cat",
    "Liver Cancer Translational Research Group - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Liver Unit-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain",
    "Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy",
    "Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy",
    "Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy",
    "Department of Surgery, HPB Surgery and Liver Transplantation, Instituto Nazionale Tumori IRCCS, Milan, Italy",
    "Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria",
    "Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA",
    "State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China",
    "Department of Medicine (Gastroenterology and Hepatology), Northwestern University Feinberg School of Medicine, Chicago, IL, USA",
    "Department of Internal Medicine, University of Chicago, Chicago, IL, USA",
    "Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA",
    "Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain",
    "Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra, Madrid, Spain",
    "European Liver Patients' Association (ELPA), Barcelona, Spain",
    "Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA",
    "The Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA, USA",
    "Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany",
    "Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada",
    "The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA",
    "Royal Free Hospital and UCL Cancer Institute, University College London, London, UK",
    "Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA",
    "Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA"
  ],
  "article_type": "review",
  "arxiv": null,
  "author_total": 18,
  "authors": [
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Josep Maria Llovet",
      "orcid": "0000-0003-0547-2667"
    },
    {
      "affs": [
        3
      ],
      "name": "Ezequiel Mauro",
      "orcid": "0000-0002-0757-7676"
    },
    {
      "affs": [
        4,
        5
      ],
      "name": "Lorenza Rimassa",
      "orcid": "0000-0001-9957-3615"
    },
    {
      "affs": [
        6,
        7
      ],
      "name": "Vincenzo Mazzaferro",
      "orcid": "0000-0002-4013-8085"
    },
    {
      "affs": [
        8
      ],
      "name": "Matthias Pinter",
      "orcid": "0000-0002-7260-532X"
    },
    {
      "affs": [
        9
      ],
      "name": "Robin Kate Kelley",
      "orcid": "0000-0002-1984-2430"
    },
    {
      "affs": [
        10
      ],
      "name": "Stephen Lam Chan",
      "orcid": "0000-0001-8998-5480"
    },
    {
      "affs": [
        11
      ],
      "name": "Laura Kulik",
      "orcid": "0000-0002-0169-9795"
    },
    {
      "affs": [
        12
      ],
      "name": "Anjana A Pillai",
      "orcid": "0000-0001-6783-2109"
    },
    {
      "affs": [
        13
      ],
      "name": "Lewis Rowland Roberts",
      "orcid": "0000-0001-7885-8574"
    },
    {
      "affs": [
        14,
        15
      ],
      "name": "Bruno Sangro",
      "orcid": "0000-0002-4177-6417"
    },
    {
      "affs": [
        16
      ],
      "name": "Teresa Casanovas"
    },
    {
      "affs": [
        17,
        18
      ],
      "name": "David Edward Kaplan",
      "orcid": "0000-0002-3839-336X"
    },
    {
      "affs": [
        19,
        20
      ],
      "name": "Arndt Vogel",
      "orcid": "0000-0003-0560-5538"
    },
    {
      "affs": [
        21
      ],
      "name": "Mark M. Yarchoan",
      "orcid": "0000-0003-4401-0748"
    },
    {
      "affs": [
        22
      ],
      "name": "Richard S. Finn",
      "orcid": "0000-0003-2494-2126"
    },
    {
      "affs": [
        23
      ],
      "name": "Tim Meyer",
      "orcid": "0000-0003-0782-8647"
    },
    {
      "affs": [
        24
      ],
      "name": "Amit G. Singal",
      "orcid": "0000-0002-1172-3971"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/e3nsyzp93wp9z.bib",
  "cited_by": 13,
  "doi": "10.1038/s41571-026-01160-z",
  "fulltext_url": null,
  "id": "e3nsyzp93wp9z",
  "issns": [
    "1759-4774",
    "1759-4782"
  ],
  "landing_url": "https://doi.org/10.1038/s41571-026-01160-z",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2721|Hepatocellular Carcinoma Treatment and Prognosis"
    ]
  ],
  "openalex": "W7164128521",
  "pdf_url": "https://www.nature.com/articles/s41571-026-01160-z.pdf",
  "pmcid": "PMC13665261",
  "pmid": "42270817",
  "published": "2026-06-10",
  "publisher": "Nature Portfolio",
  "ris": "https://research.draconitic.com/paper/e3nsyzp93wp9z.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T13:26:56Z",
      "native_id": "W7164128521",
      "source": "openalex",
      "url": "https://doi.org/10.1038/s41571-026-01160-z"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2721|Hepatocellular Carcinoma Treatment and Prognosis",
      "subfield": "general"
    }
  ],
  "title": "Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement",
  "title_text": "Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T13:21:16Z",
  "url": "https://research.draconitic.com/paper/e3nsyzp93wp9z",
  "venue": "Nature Reviews Clinical Oncology",
  "versions": []
}